Christopher P Evans, MD

Professor

  • 7348 Citations
  • 45 h-Index
1988 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christopher P Evans is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Castration Medicine & Life Sciences
Androgens Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostate Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2021

CANCER CENTER SUPPORT GRANT-P30

DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Lloyd, K. C. K. & Chen, M.

National Institutes of Health

7/1/026/30/21

Project: Research project

Neoplasms
Organized Financing
Research
Research Personnel
Clinical Trials
Nerve Growth Factors
Protein-Tyrosine Kinases
Prostatic Neoplasms
Cell Movement
Neuroendocrine Cells

Research Output 1988 2019

AKR1C3 promotes AR-V7 protein stabilization and confers resistance to AR-targeted therapies in advanced prostate cancer

Liu, C., Yang, J. C., Armstrong, C. M., Lou, W., Liu, L., Qiu, X., Zou, B., Lombard, A. P., D'Abronzo, L. S., Evans, C. P. & Gao, A. C., Jan 1 2019, In : Molecular Cancer Therapeutics. 18, 10, p. 1875-1886 12 p.

Research output: Contribution to journalArticle

Androgen Receptors
Prostatic Neoplasms
Proteins
Indomethacin
Therapeutics
4 Citations (Scopus)

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

Chen, W. S., Aggarwal, R., Zhang, L., Zhao, S. G., Thomas, G. V., Beer, T. M., Quigley, D. A., Foye, A., Playdle, D., Huang, J., Lloyd, P., Lu, E., Sun, D., Guan, X., Rettig, M., Gleave, M., Evans, C. P., Youngren, J., True, L., Lara, P. N. & 8 others, Kothari, V., Xia, Z., Chi, K. N., Reiter, R. E., Maher, C. A., Feng, F. Y., Small, E. J. & Alumkal, J. J., Jan 1 2019, In : European Urology.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Catenins
Survival Analysis
Survival

GnRH antagonists have direct inhibitory effects on castration-resistant prostate cancer via intracrine androgen and AR-V7 expression

Cucchiara, V., Yang, J. C., Liu, C., Adomat, H. H., Tomlinson Guns, E. S., Gleave, M. E., Gao, A. C. & Evans, C. P., Jan 1 2019, In : Molecular Cancer Therapeutics. 18, 10, p. 1811-1821 11 p.

Research output: Contribution to journalArticle

Hormone Antagonists
Castration
Gonadotropin-Releasing Hormone
Androgens
Prostatic Neoplasms
1 Citation (Scopus)

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

Nickols, N. G., Nazarian, R., Zhao, S. G., Tan, V., Uzunangelov, V., Xia, Z., Baertsch, R., Neeman, E., Gao, A. C., Thomas, G. V., Howard, L., De Hoedt, A. M., Stuart, J., Goldstein, T., Chi, K., Gleave, M. E., Graff, J. N., Beer, T. M., Drake, J. M., Evans, C. P. & 11 others, Aggarwal, R., Foye, A., Feng, F. Y., Small, E. J., Aronson, W. J., Freedland, S. J., Witte, O. N., Huang, J., Alumkal, J. J., Reiter, R. E. & Rettig, M. B., Jan 1 2019, In : Prostate Cancer and Prostatic Diseases.

Research output: Contribution to journalArticle

Open Access
Castration
Mitogen-Activated Protein Kinase Kinases
Prostatic Neoplasms
Therapeutics
Phosphotransferases

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer

Lombard, A. P., Liu, C., Armstrong, C. M., D'Abronzo, L. S., Lou, W., Chen, H., Dall'Era, M., Ghosh, P. M., Evans, C. P. & Gao, A. C., Jul 1 2019, In : Translational Oncology. 12, 7, p. 871-878 8 p.

Research output: Contribution to journalArticle

Open Access
Prostatic Neoplasms
Therapeutics
Poly(ADP-ribose) Polymerases
Castration
docetaxel